(0.55%) 5 074.25 points
(0.33%) 38 193 points
(0.74%) 17 567 points
(0.81%) $79.64
(2.54%) $1.981
(0.10%) $2 313.20
(-0.27%) $26.68
(0.72%) $961.80
(0.09%) $0.934
(0.35%) $11.07
(-0.02%) $0.798
(-1.51%) $91.85
4 days till quarter result
(bmo 2024-05-06)
Expected move: +/- 0.00%
-1.54% € 51.30
Live Chart Being Loaded With Signals
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide...
Stats | |
---|---|
Tagesvolumen | 97 095.00 |
Durchschnittsvolumen | 650 558 |
Marktkapitalisierung | 57.24B |
EPS | €0 ( 2024-02-01 ) |
Nächstes Ertragsdatum | ( €0.520 ) 2024-05-06 |
Last Dividend | €0.950 ( 2023-02-16 ) |
Next Dividend | €0 ( N/A ) |
P/E | 38.00 |
ATR14 | €0.0410 (0.08%) |
Volumen Korrelation
Siemens Healthineers AG Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Siemens Healthineers AG Korrelation - Währung/Rohstoff
Siemens Healthineers AG Finanzdaten
Annual | 2023 |
Umsatz: | €21.68B |
Bruttogewinn: | €7.71B (35.56 %) |
EPS: | €1.350 |
FY | 2023 |
Umsatz: | €21.68B |
Bruttogewinn: | €7.71B (35.56 %) |
EPS: | €1.350 |
FY | 2022 |
Umsatz: | €21.71B |
Bruttogewinn: | €8.14B (37.47 %) |
EPS: | €1.820 |
FY | 2021 |
Umsatz: | €18.00B |
Bruttogewinn: | €6.95B (38.63 %) |
EPS: | €1.724 |
Financial Reports:
No articles found.
Siemens Healthineers AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0.950 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.700 | 2019-02-06 |
Last Dividend | €0.950 | 2023-02-16 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | €4.10 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.9 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.58 | |
Div. Directional Score | 7.83 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
NXU.DE | Ex Dividend Knight | 2023-05-17 | Annually | 0 | 0.00% | |
AEIN.DE | Ex Dividend Knight | 2023-06-14 | Annually | 0 | 0.00% | |
GRM.DE | Ex Dividend Knight | 2023-07-07 | Quarterly | 0 | 0.00% | |
RHK.DE | Ex Dividend Junior | 2023-06-09 | Sporadic | 0 | 0.00% | |
BMW.DE | Ex Dividend Junior | 2023-05-12 | Annually | 0 | 0.00% | |
INS.DE | Ex Dividend Junior | 2023-06-15 | Annually | 0 | 0.00% | |
SZG.DE | Ex Dividend Junior | 2023-05-26 | Annually | 0 | 0.00% | |
CVS.DE | Ex Dividend Knight | 2023-10-19 | Quarterly | 0 | 0.00% | |
LXS.DE | Ex Dividend Junior | 2023-05-25 | Annually | 0 | 0.00% | |
2GB.DE | Ex Dividend Junior | 2023-06-14 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0697 | 1.500 | 8.61 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0333 | 1.200 | 8.89 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0862 | 1.500 | -0.153 | -0.230 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.116 | 0.800 | 9.42 | 7.54 | [1 - 3] |
quickRatioTTM | 0.697 | 0.800 | -0.608 | -0.486 | [0.8 - 2.5] |
cashRatioTTM | 0.118 | 1.500 | -0.455 | -0.682 | [0.2 - 2] |
debtRatioTTM | 0.0147 | -1.500 | 9.75 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 6.52 | 1.000 | 8.70 | 8.70 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.12 | 2.00 | 9.29 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.430 | 2.00 | 9.28 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0376 | -1.500 | 9.85 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.359 | 1.000 | 7.35 | 7.35 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.107 | 1.000 | 9.86 | 9.86 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 3.53 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.478 | 0.800 | -0.144 | -0.116 | [0.5 - 2] |
Total Score | 10.09 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.30 | 1.000 | 6.23 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0862 | 2.50 | -0.0985 | -0.230 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.430 | 2.00 | 9.52 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.823 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.12 | 2.00 | 9.29 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 2.40 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.109 | 1.000 | 9.78 | 0 | [0.1 - 0.5] |
Total Score | 5.58 |
Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.